WATERTOWN, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, ...
Two months after rejecting Pierre Fabre’s Braftovi for a rare form of metastatic colorectal cancer ... people diagnosed with bowel cancer who have a BRAF V600E mutation are currently extremely ...
Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...
We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a look at where Pfizer Inc.
BEACON CRC (binimetinib [BINI], encorafenib [ENCO], and cetuximab [CTX] combined to treat BRAF-mutant metastatic colorectal cancer [mCRC]): A multicenter ... ENCO + BINI + CTX in patients (Pts) with ...
When combined with chemotherapy, cetuximab shows promising efficacy for optimizing treatment strategies for patients with ...
A new research paper was published in , Volume 16, on February 18, 2025, titled "Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters' model: A regenerative approach using ...
Colon cancer develops when tumorous growths form in the large intestine. It often produces no symptoms in the early stages, but people should see a doctor if they notice persistent changes in ...
Long-Term Yogurt Consumption Tied to Decreased Incidence of Certain Types of Colorectal Cancer Feb. 12, 2025 — Researchers looked at the role of long-term diet and the gut bacteria in colorectal ...
This new analysis helps explain some of the confusion. Epidemiologists did not find a significant association between yogurt and the overall incidence of colorectal cancer – the third most common ...
If cancer is close to the surface of the skin and has caused an ulcerated mass to form, this can become a breeding ground for bacteria. The infection that results can then cause a foul odor. There may ...